Entity

Time filter

Source Type

Bozeman, MT, United States

Patent
LigoCyte Pharmaceuticals | Date: 2010-04-22

The present invention relates to vaccine compositions comprising


Patent
LigoCyte Pharmaceuticals | Date: 2010-06-16

The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.


Patent
LigoCyte Pharmaceuticals | Date: 2013-03-15

The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.


Patent
LigoCyte Pharmaceuticals | Date: 2013-03-15

The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.


Methods of stabilizing solutions with enveloped vims-based virus-like particles containing an influenza antigen and such stabilized solutions are described.

Discover hidden collaborations